PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway

Table 1 The relationship between PPP2R1B and 100 CRC patients clinical pathology data

Parameters	No. of patients	Expression of PPP2R1B		P value
Parameters	No. of patients	Low (62)	High (38)
Age (years)				0.82
< 60	42	25	17
≥ 60	58	37	21
Gender				0.73
Male	57	34	23
Female	43	28	15
Size (maximal diameter)				0.68
≥ 5 cm	46	30	16
< 5 cm	54	32	22
Differentiation				0.07
Well, moderate	60	42	18
Poor	40	20	20
TNM stage				0.02
I + II	58	30	28
III + IV	42	32	10
Tumor invasion				0.22
T1 + T2 + T3	69	46	23
T4	31	16	15
Lymph node status				0.33
Positive	60	40	20
Negative	40	22	18
Metastasis				0.03
M0	83	47	36
M1	17	15	2

ISSN: 1475-2867